Chugai Pharma seeks Japanese additional approval for anti-cancer agents Herceptin & Xeloda
Saturday, March 20, 2010 09:00 IST Tokyo
Chugai Pharmaceutical Co, Ltd announced that it filed an application with the Japanese Ministry of Health, Labour and Welfare, seeking additional approval of combination therapy